The introduction of immune checkpoint inhibitors (ICIs) for advanced and metastatic forms of non-melanoma skin cancers (NMSC) has changed management, adding both opportunities and challenges. In this webinar, nurses will gain a practical understanding of the role of ICIs in NMSC management, including how they work, how to communicate safety and efficacy expectations to patients, safe administration and handling practices, how to recognize and characterize immune-related adverse events (irAEs), including why irAEs happen, and how to differentiate life-threatening irAEs from common side effects. The presentation will be coupled with a series of case studies and a live Q&A session with Nurse Practitioner Krista M. Rubin, MS, RN, FNP-BC. This webinar will empower nurses to communicate ICI treatment plans to patients with confidence and engage them as advocates in their own care.
4 Live Webinars | Join Us
Upon completion of this activity, participants should be better able to:
Nurse Practitioner, Center for Melanoma/Cutaneous Oncology
Mass General Cancer Center
Boston, MA
RMEI Medical Education, LLC (RMEI) requires instructors, planners, managers, and others in control of educational content to disclose all their financial relationships with ineligible companies over the previous 24 months. All identified financial relationships are thoroughly vetted and mitigated according to RMEI policy. RMEI will disclose to learners the presence or absence of relevant financial relationships for all persons in control of content before the learner engages in the education.
Krista M. Rubin, MS, RN, FNP-BC, has relevant financial relationship(s) with Immunocore (Consultant).
All of the relevant financial relationships listed for this individual have been mitigated according to RMEI policies.
In support of improving patient care, RMEI Medical Education, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour(s).
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources
